entity

CYP2C19

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CYP2C19: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

63Connections
0Hypotheses
0Analyses
47Outgoing
16Incoming

Wiki Pages (14)

Knowledge base pages for this entity

Riluzole ALS Trials

clinical · 3263 words

LY03020 - Luye Pharma Phase 1 Trial

clinical · 3130 words

NAB-IT: Nabilone for Agitation in Alzheimer's Disease

clinical · 2996 words

Section 216: Advanced Pharmacogenomics for CBS/PSP

therapeutic · 2181 words

Primidone

treatment · 2178 words

Outgoing (47)

TargetRelationTypeStr
antidepressant drugsmodulatesdrug0.85
CYP2D6associated_withgene0.60
CYP3A4associated_withgene0.60
DRD2associated_withgene0.60
GCH1associated_withgene0.60

Incoming (16)

SourceRelationTypeStr
ABCB1associated_withgene0.60
APOEassociated_withgene0.60
ABCG2associated_withgene0.60
ADRA2Aassociated_withgene0.60
ADRB2associated_withgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found